Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diag...
FDA Device Recall #Z-0341-2016 — Class II — September 3, 2015
Recall Summary
| Recall Number | Z-0341-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 3, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Leica Microsystems, Inc. |
| Location | Buffalo Grove, IL |
| Product Type | Devices |
| Quantity | U.S: 1 unit of CD10-270-CE-S & 66 units of CD10-270-CE. Foreign: 83 units of CD10-270-CE-S & 219 units of CD10-270-CE |
Product Description
Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diagnostic. 0.1ml NCL-CD10-270 and 1mL NCL-CD10-270 are intended for the qualitative identification by light microscopy of CD10 molecules in paraffin sections.
Reason for Recall
These Lot numbers are not stable up to the expiry date on the product labeling.
Distribution Pattern
Worldwide Distribution - US Nationwide, Australia, Austria, Brazil, Canada, China, Czech Republic, Finland, France, Germany, Hungary, Indonesia, Ireland, Israel, Italy, Japan, Netherlands, Norway, Romania, Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland and UK.
Lot / Code Information
CD10-270-CE-S (0.1 ml) 6033086 (U.S. Distribution) expire 06/2016, 6032390 expires 04/2016, 6033622 expires 07/2016. CD10-270-CE (1ml) 6032742 (U.S. Distribution) expires 11/2017.
Other Recalls from Leica Microsystems, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0477-2023 | Class II | Leica MICROSYSTEMS M530 OHX, Part Number 104487... | Nov 21, 2022 |
| Z-0476-2023 | Class II | Leica MICROSYSTEMS Provido, Part Numbers 104489... | Nov 21, 2022 |
| Z-0475-2023 | Class II | Leica MICROSYSTEMS Proveo 8, Part Number 104490... | Nov 21, 2022 |
| Z-1849-2022 | Class II | Leica Surgical Operating Microscopes, Arveo, Pa... | Aug 26, 2022 |
| Z-1848-2022 | Class II | Leica Surgical Operating Microscopes, ARveo 8, ... | Aug 26, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.